On October 1, 2013, Luoxis Diagnostics (a subsidiary of Ampio Pharmaceuticals, Inc) announced the results of its five year multi-center study on the use of a device at bedside to predict the outcome of severe TBI. The results confirmed that measurement of ORP is an accurate gauge to outcome. ORP stands for oxidation-reduction-potential.